Cargando…
Feasibility and safety of cCD20 RNA CAR-bearing T cell therapy for the treatment of canine B cell malignancies
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646055/ http://dx.doi.org/10.1186/2051-1426-3-S2-P123 |
| _version_ | 1782400912798515200 |
|---|---|
| author | Smith, Jenessa B Panjwani, M Kazim Schutsky, Keith Gnanandarajah, Josephine Calhoun, Sondra Cooper, Laurence Mason, Nicola Powell, Daniel J |
| author_facet | Smith, Jenessa B Panjwani, M Kazim Schutsky, Keith Gnanandarajah, Josephine Calhoun, Sondra Cooper, Laurence Mason, Nicola Powell, Daniel J |
| author_sort | Smith, Jenessa B |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4646055 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46460552015-11-20 Feasibility and safety of cCD20 RNA CAR-bearing T cell therapy for the treatment of canine B cell malignancies Smith, Jenessa B Panjwani, M Kazim Schutsky, Keith Gnanandarajah, Josephine Calhoun, Sondra Cooper, Laurence Mason, Nicola Powell, Daniel J J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4646055/ http://dx.doi.org/10.1186/2051-1426-3-S2-P123 Text en Copyright © 2015 Smith et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Smith, Jenessa B Panjwani, M Kazim Schutsky, Keith Gnanandarajah, Josephine Calhoun, Sondra Cooper, Laurence Mason, Nicola Powell, Daniel J Feasibility and safety of cCD20 RNA CAR-bearing T cell therapy for the treatment of canine B cell malignancies |
| title | Feasibility and safety of cCD20 RNA CAR-bearing T cell therapy for the treatment of canine B cell malignancies |
| title_full | Feasibility and safety of cCD20 RNA CAR-bearing T cell therapy for the treatment of canine B cell malignancies |
| title_fullStr | Feasibility and safety of cCD20 RNA CAR-bearing T cell therapy for the treatment of canine B cell malignancies |
| title_full_unstemmed | Feasibility and safety of cCD20 RNA CAR-bearing T cell therapy for the treatment of canine B cell malignancies |
| title_short | Feasibility and safety of cCD20 RNA CAR-bearing T cell therapy for the treatment of canine B cell malignancies |
| title_sort | feasibility and safety of ccd20 rna car-bearing t cell therapy for the treatment of canine b cell malignancies |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646055/ http://dx.doi.org/10.1186/2051-1426-3-S2-P123 |
| work_keys_str_mv | AT smithjenessab feasibilityandsafetyofccd20rnacarbearingtcelltherapyforthetreatmentofcaninebcellmalignancies AT panjwanimkazim feasibilityandsafetyofccd20rnacarbearingtcelltherapyforthetreatmentofcaninebcellmalignancies AT schutskykeith feasibilityandsafetyofccd20rnacarbearingtcelltherapyforthetreatmentofcaninebcellmalignancies AT gnanandarajahjosephine feasibilityandsafetyofccd20rnacarbearingtcelltherapyforthetreatmentofcaninebcellmalignancies AT calhounsondra feasibilityandsafetyofccd20rnacarbearingtcelltherapyforthetreatmentofcaninebcellmalignancies AT cooperlaurence feasibilityandsafetyofccd20rnacarbearingtcelltherapyforthetreatmentofcaninebcellmalignancies AT masonnicola feasibilityandsafetyofccd20rnacarbearingtcelltherapyforthetreatmentofcaninebcellmalignancies AT powelldanielj feasibilityandsafetyofccd20rnacarbearingtcelltherapyforthetreatmentofcaninebcellmalignancies |